| Proportion colonised (%) | |||||
---|---|---|---|---|---|---|
Resistance phenotype | July 2012f | October 2012f | January 2013f | May 2013f | August 2013f | Any time point |
ESBL-EC a | 20/51 (39%) | 21/51 (41%)7 | 14/50 (28%) | 21/49 (43%)7 | 19/45 (42%)7 | 35/64 (55%) |
ESBL - KP b | 0/51 (0%) | 2/51 (4%) | 0/50 (0%) | 2/49 (4%) | 2/45 (4%) | 5/64 (8%) |
CPE c | 0/51 (0%) | 0/51 (0%) | 0/50 (0%) | 0/49 (0%) | 0/45 (0%) | 0/64 0%) |
VRE d | 0/51 (0%) | 0/51 (0%) | 1/50 (2%) | 1/49 (2%) | 1/45 (2%) | 2/64 (3%) |
MRSA e | 8/51 (16%) | 9/51 (18%) | 7/50 (14%) | 7/49 (14%) | 4/45 (9%) | 17/64 (27%) |
Any of above | 24/51 (47%) | 25/51 (49%) | 17/50 (34%) | 23/49 (47%) | 20/45 (44%) | 39/64 (61%) |